Happy Health wins FDA clearance for cuffless blood pressure tracking in smart ring

Happy Health says the FDA cleared its Happy Ring to measure ongoing blood pressure without a cuff or external calibration, a first for a wearable device. The clearance could expand home monitoring for hypertension and link blood pressure data with the ring’s existing sleep apnea capabilities.

Why it matters: - Continuous blood pressure tracking could move care beyond one-off clinic readings and help spot risk overnight, when blood pressure can be most revealing. - The clearance removes two common barriers in wearables: inflatable cuffs and daily calibration. - Happy Health says the device can pair blood pressure data with sleep apnea monitoring, which may help physicians connect two conditions that often overlap.

What happened: - Happy Health said the FDA cleared its Happy Ring to measure ongoing, clinical-grade blood pressure. - The company described the Happy Ring as the first wearable cleared for passive blood pressure measurement without an inflatable cuff or calibration. - Happy Health announced the clearance on Oct. 5, 2026. - The company is based in Texas and focuses on physician-guided care in the home.

The details: - Happy Health validated the blood pressure technology against invasive arterial-line measurements, a clinical reference standard. - The FDA validation included 850 paired measurements across 85 patients. - The study covered normal blood pressure through Stage 2 hypertension. - Participants included a range of ages, sexes, BMIs and skin tones, and no subjects were excluded from analysis. - The company reported mean error of 0.8 mmHg for systolic blood pressure and 0.1 mmHg for diastolic blood pressure. - The Happy Ring captures more than 2.8 million medical data points each night across sleep, respiratory, cardiovascular, neurological and metabolic systems. - Happy Health said its platform uses AI to build a personalized model of each person’s health and detect changes against that baseline. - Board-certified physicians in Happy Health’s 50-state network interpret results, make clinical decisions and guide diagnosis and care. - The Happy Ring already has FDA-cleared at-home sleep apnea diagnosis capabilities. - Happy Health says the device is the first and only FDA-cleared smart ring for at-home diagnosis of obstructive sleep apnea. - The company says the sleep apnea workflow can support a physician-rendered diagnosis in as few as five nights with 98% accuracy versus in-lab polysomnography.

Between the lines: - The clearance puts Happy Health in a rare category of consumer wearables that can generate medical-grade blood pressure data without a cuff. - The company is framing the product as part of a broader shift from spot checks to continuous, personalized monitoring. - Happy Health is also positioning sleep apnea as a clinical gateway, since untreated sleep apnea is a common driver of high blood pressure. - The reference to nighttime blood pressure matters because overnight readings can be more predictive of mortality risk than office measurements.

What's next: - Happy Health is likely to push the Happy Ring as a home-based tool for physicians managing hypertension and sleep apnea together. - The company’s 50-state physician network gives it a route to turn wearable data into diagnosis and treatment decisions. - Happy Health raised $75 million from ARCH Venture Partners and OpenLoop in August 2026, which should support commercialization and product expansion. - As the platform gathers more longitudinal data, the company appears set to refine individualized health baselines and detection algorithms.

The bottom line: - Happy Health now has FDA clearance for cuffless, calibrationless blood pressure monitoring in a smart ring, a notable step toward continuous home-based cardiovascular tracking.